Skip to main content
National News Desk
health

Health ministry proposes amendment to drug rules to bring antimicrobials under regulatory oversight

Hindustan Times IndiaBy Hindustan Times India
19 Nov 2026
Original: English
AI Synopsis & Key Briefing

Health ministry proposes amendment to drug rules to bring antimicrobials under regulatory oversight

Key Highlights & Official Takeaways
  • ✓Health ministry proposes amendment to drug rules to bring antimicrobials under regulatory oversight
  • ✓Antimicrobial resistance (AMR) is a major global public health concern and a priority requiring coordinated action, the ministry said.
  • ✓The proposed amendment seeks to bring antimicrobials within the regulatory framework applicable to new drugs under the 2019 rules.
  • ✓This is expected to strengthen the Central regulatory oversight and help ensure the quality, safety and efficacy of antimicrobial products, the ministry said.
Comprehensive News & Policy Report

New Delhi, Nov 19 (PTI) The Ministry of Health and Family Welfare has proposed bringing antimicrobials under the Central regulatory framework applicable to new drugs to strengthen oversight of their quality, safety and efficacy and address antimicrobial resistance.

Health ministry proposes amendment to drug rules to bring antimicrobials under regulatory oversightIt has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, through a draft gazette notification dated November 6, seeking to include antimicrobials in the definition of new drug under Rule 2(1)(w)(v).

Antimicrobial resistance (AMR) is a major global public health concern and a priority requiring coordinated action, the ministry said. The G20 New Delhi Leaders' Declaration also underscored the need to address antimicrobial resistance through a 'One Health' approach.

"The proposed amendment has been initiated in view of concerns regarding the grant of manufacturing licences for antimicrobial products without adequate regulatory scrutiny, including the requirement for studies such as bioavailability/bioequivalence and stability studies," the ministry said.

"The absence of such assessments may affect the quality, safety and efficacy of antimicrobial products. Substandard or ineffective antimicrobials can contribute to the development and spread of antimicrobial resistance, posing risks to patient safety," it added.

The proposed amendment seeks to bring antimicrobials within the regulatory framework applicable to new drugs under the 2019 rules. Accordingly, manufacturers would be required to obtain permission from the Central Licensing Authority (CLA) before applying for a manufacturing licence from the concerned State Licensing Authority (SLA).

This is expected to strengthen the Central regulatory oversight and help ensure the quality, safety and efficacy of antimicrobial products, the ministry said. The draft notification invites objections and suggestions from stakeholders and members of the public before the proposed amendment is considered for finalisation by the Centre.

Antimicrobials are agents that kill microorganisms or stop their growth. They include medicines used to treat or prevent infections, as well as substances applied to skin or surfaces to reduce microbes.

Actionable Steps for Aspirants & Citizens
  • •Aspirants and citizens are advised to monitor official notices and circulars issued by Hindustan Times India.
  • •Verify all prescribed eligibility criteria, cutoff dates, and authenticated document requirements prior to formal submissions.
  • •Track connected examination timetables, vacancy advisories, and administrative gazettes on SuchnaSetu.
Official Notice Specification
Issuing AuthorityHindustan Times India
Topic CategoryHEALTH
JurisdictionAll India / National
Publication Date19 November 2026
Connected Government Jobs & Upcoming Exams
Active on SuchnaSetu
Official Source Attribution: Hindustan Times India
View Publisher Source Link

SuchnaSetu provides verified civic and public policy reports based on official notices. Primary publication and copyright remain with the respective government authority or publisher.